Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
AUTOR(ES)
Buratti, Emanuele
FONTE
Oxford University Press
RESUMO
Alternative splicing of human cystic fibrosis transmembrane conductance regulator (CFTR) exon 9 is regulated by a combination of cis-acting elements distributed through the exon and both flanking introns (IVS8 and IVS9). Several studies have identified in the IVS8 intron 3′ splice site a regulatory element that is composed of a polymorphic (TG)m(T)n repeated sequence. At present, no cellular factors have been identified that recognize this element. We have identified TDP-43, a nuclear protein not previously described to bind RNA, as the factor binding specifically to the (TG)m sequence. Transient TDP-43 overexpression in Hep3B cells results in an increase in exon 9 skipping. This effect is more pronounced with concomitant overexpression of SR proteins. Antisense inhibition of endogenous TDP-43 expression results in increased inclusion of exon 9, providing a new therapeutic target to correct aberrant splicing of exon 9 in CF patients. The clinical and biological relevance of this finding in vivo is demonstrated by our characterization of a CF patient carrying a TG10T9(ΔF508)/TG13T3(wt) genotype leading to a disease-causing high proportion of exon 9 skipping.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=145463Documentos Relacionados
- Atypical 5′ Splice Sites Cause CFTR Exon 9 To Be Vulnerable to Skipping
- Rapamycin Rescues TDP-43 Mislocalization and the Associated Low Molecular Mass Neurofilament Instability
- Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis
- Exon skipping by overexpression of a Drosophila heterogeneous nuclear ribonucleoprotein in vivo.
- TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases*